心脏病中的RAS病变
Saravanakkumar Chennappan1, Maria Irene Kontaridis2,3,1
1Department of Biomedical Research and Translational Medicine, Masonic Medical Research Institute, Utica, New York, USA;
Annual review of medicine
|November 22, 2024
概括
影响Ras-MAPK通路的遗传性疾病RASopathies对婴儿高性心肌病治疗提出了重大挑战. 目前的疗法可以控制症状,但需要针对疾病原因的新策略.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 心脏病学 心脏病学
背景情况:
- 拉索发病是一种罕见的自体主导性疾病,源于Ras-MAPK信号通路中的突变.
- 总的来说,这些情况代表着一大群先天性疾病,其中婴儿多变性心肌病是显著的表现.
- 尽管五十年来进行了广泛的研究,但对RASopathies的有效病因治疗仍然难以捉摸.
研究的目的:
- 审查开发针对RAS病症的向治疗的挑战.
- 专门解决与RASopathies相关的先天性心脏缺陷和心脏病治疗的局限性.
- 讨论RASopathies的未来方向和潜在的治疗策略.
主要方法:
- 对RASopathy研究的文献综述.
- 针对Ras-MAPK通路基因和调节节点的挑战分析.
- 专注于先天性心脏缺陷和心脏表现.
主要成果:
- 对RAS病的治疗选择有限,主要是症状性.
- 针对RAS病变的因果基因和调节途径是复杂的.
- 在RASopathies中,先天性心脏缺陷带来了特殊的治疗挑战.
结论:
- 开发RAS病,特别是心脏病的病因治疗方法,需要创新的方法.
- 克服途径和基因向方面的挑战对于未来的治疗进展至关重要.
- 对新型治疗策略的进一步研究对于改善RAS病患者的治疗结果至关重要.
相关概念视频
Rheumatic Heart Disease I: Introduction
3
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
7
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
59
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
59
Mechanism of Cardiac Arrhythmias
891
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
891
Rheumatic Heart Disease IV: Nursing Management
4
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
4
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103


